Propranolol oral pour traiter l'hémangiome infantile = Oral propranolol for infantile hemangiomaThe Medical letter on drugs and therapeutics (Edition française). 2014, Vol 36, Num 17, pp 75-76, issn 0253-8512, 2 p.Article

Multiplicity of effectors of the cardioprotective agent, diazoxideCOETZEE, William A.Pharmacology & therapeutics (Oxford). 2013, Vol 140, Num 2, pp 167-175, issn 0163-7258, 9 p.Article

Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?ROCHETTE, Luc; LORIN, Julie; ZELLER, Marianne et al.Pharmacology & therapeutics (Oxford). 2013, Vol 140, Num 3, pp 239-257, issn 0163-7258, 19 p.Article

Regulation of Angiotensin II Receptor Expression : Angiotensin II Receptor ResearchICHIKI, Toshihiro.Current pharmaceutical design (Print). 2013, Vol 19, Num 17, pp 3013-3021, issn 1381-6128, 9 p.Article

Riociguat: First Global ApprovalCONOLE, Daniel; SCOTT, Lesley J.Drugs (Basel). 2013, Vol 73, Num 17, pp 1967-1975, issn 0012-6667, 9 p.Article

Synthesis and structure—activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonistsWANG, Yan-Xiang; LI WANG; SONG, Dan-Qing et al.European journal of medicinal chemistry. 2011, Vol 46, Num 4, pp 1066-1073, issn 0223-5234, 8 p.Article

The Potential Role of Erythropoietin as a Pleiotropic Agent in Post-cardiac Arrest SyndromeXANTHOS, Theodoros; VASILEIOU, Panagiotis V. S; KAKAVAS, Sotirios et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 15, pp 1517-1529, issn 1381-6128, 13 p.Article

The GAF-Tandem Domain of Phosphodiesterase 5 as a Potential Drug TargetSCHULTZ, Joachim E; DUNKERN, Torsten; GAWLITTA-GORKA, Elvira et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 151-166, issn 0171-2004, 16 p.Article

3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA)JIN AH JEONG; CHO, Haelim; SOO YEON JUNG et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 1, pp 38-41, issn 0960-894X, 4 p.Article

Differential effects of β-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exerciseCOCKBURN, James A; BRETT, Sally E; GUILCHER, Antoine et al.British journal of clinical pharmacology. 2010, Vol 69, Num 4, pp 329-335, issn 0306-5251, 7 p.Article

Synthesis and antioxidant activity evaluation of a syringic hydrazones familyBELKHEIRI, Nadji; BOUGUERNE, Benaissa; BEDOS-BELVAL, Florence et al.European journal of medicinal chemistry. 2010, Vol 45, Num 7, pp 3019-3026, issn 0223-5234, 8 p.Article

Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitorsGOODMAN, Krista B; BURY, Michael J; DEYOU SHA et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 1, pp 27-30, issn 0960-894X, 4 p.Article

Novel _L-adenosine analogs as cardioprotective agentsKASIGANESAN, Harinath; WRIGHT, Gary L; ASSUNTA CHIACCHIO, Maria et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 14, pp 5347-5352, issn 0968-0896, 6 p.Article

Synthesis and bioactivity of substituted indan-1-ylidene aminoguanidine derivativesRUI ZHANG; JIN DONG; XU, Yun-Gen et al.European journal of medicinal chemistry. 2009, Vol 44, Num 9, pp 3771-3776, issn 0223-5234, 6 p.Article

Na⁺ Currents in Cardioprotection: Better to Be LateLE GRAND, Bruno; PIGNIER, Christophe; LETIENNE, Robert et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 14, pp 4149-4160, issn 0022-2623, 12 p.Article

Peptides Targeting Angiogenesis Related Growth Factor ReceptorsD'ANDREA, Luca D; DEL GATTO, Annarita; DE ROSA, Lucia et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 21, pp 2414-2429, issn 1381-6128, 16 p.Article

Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agentsFOTOPOULOU, Theano; ILIODROMITIS, Efstathios K; KOUFAKI, Maria et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 8, pp 4523-4531, issn 0968-0896, 9 p.Article

Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors : SAR, synthesis, and modeling evaluationTEGLEY, Christopher M; VISWANADHAN, Vellarkad N; YODER, Sean C et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 14, pp 3925-3928, issn 0960-894X, 4 p.Article

Pyrano-[2,3b]-pyridines as potassium channel antagonistsFINLAY, Heather J; LLOYD, John; NYMAN, Michael et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 8, pp 2714-2718, issn 0960-894X, 5 p.Article

Pyrimidine-based inhibitors of CaMKIIδMAVUNKEL, Babu; XU, Yong-Jin; SIDERIS, Steve et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 7, pp 2404-2408, issn 0960-894X, 5 p.Article

Synthesis and discovery of a novel pyrazole derivative as an inhibitor of apoptosis through modulating integrin β4, ROS, and p53 levels in vascular endothelial cellsZHAO, Bao-Xiang; LU ZHANG; ZHU, Xing-Shang et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 9, pp 5171-5180, issn 0968-0896, 10 p.Article

Nitrosothiol stores in vascular tissue : Modulation by ultraviolet light, acetylcholine and ionomycinNG, Ella S. M; CHENG, Zhong-Jian; ELLIS, Anthie et al.European journal of pharmacology. 2007, Vol 560, Num 2-3, pp 183-192, issn 0014-2999, 10 p.Article

Pharmacological, immunological, and gene targeting of the renin-angiotensin system for treatment of cardiovascular disease : Application of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in pharmacology and therapy: An updateIGIC, Rajko; BEHNIA, Rahim.Current pharmaceutical design. 2007, Vol 13, Num 12, pp 1199-1214, issn 1381-6128, 16 p.Article

Cardiologie : Enrichir sa panoplie thérapeutique : bilan de l'année 2006 = Cardiology : 2006 updateLa Revue Prescrire. 2007, Vol 27, Num 279, pp 30-32, issn 0247-7750, 3 p.Article

Prostacyclin, atherothrombosis, and cardiovascular diseaseAREHART, E; GLEIM, S; KASZA, Z et al.Current medicinal chemistry. 2007, Vol 14, Num 20, pp 2161-2169, issn 0929-8673, 9 p.Article